These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26857460)

  • 21. EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma.
    Zhang J; Chen L; Han L; Shi Z; Zhang J; Pu P; Kang C
    Cancer Lett; 2015 Jan; 356(2 Pt B):929-36. PubMed ID: 25444902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.
    Guadagno E; Vitiello M; Francesca P; Calì G; Caponnetto F; Cesselli D; Camorani S; Borrelli G; Califano M; Cappabianca P; Arra C; Crescenzi E; Cerchia L; De Caro MLDB; Fedele M
    Oncotarget; 2017 Aug; 8(35):59282-59300. PubMed ID: 28938636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma.
    Bar EE; Chaudhry A; Lin A; Fan X; Schreck K; Matsui W; Piccirillo S; Vescovi AL; DiMeco F; Olivi A; Eberhart CG
    Stem Cells; 2007 Oct; 25(10):2524-33. PubMed ID: 17628016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.
    Liu J; Liu L; Xue Y; Meng F; Li S; Wang P; Liu Y
    Biochem Pharmacol; 2014 Jun; 89(4):477-89. PubMed ID: 24792437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
    Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
    Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IGFBP2 promotes glioma tumor stem cell expansion and survival.
    Hsieh D; Hsieh A; Stea B; Ellsworth R
    Biochem Biophys Res Commun; 2010 Jun; 397(2):367-72. PubMed ID: 20515648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiling reveals Ki-67 associated proliferation signature in human glioblastoma.
    Jin Q; Zhang W; Qiu XG; Yan W; You G; Liu YW; Jiang T; Wang L
    Chin Med J (Engl); 2011 Sep; 124(17):2584-8. PubMed ID: 22040407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptomic and Proteomic Data Integration and Two-Dimensional Molecular Maps with Regulatory and Functional Linkages: Application to Cell Proliferation and Invasion Networks in Glioblastoma.
    Gupta MK; Jayaram S; Reddy DN; Polisetty RV; Sirdeshmukh R
    J Proteome Res; 2015 Dec; 14(12):5017-27. PubMed ID: 26464075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1H NMR metabolomics analysis of glioblastoma subtypes: correlation between metabolomics and gene expression characteristics.
    Cuperlovic-Culf M; Ferguson D; Culf A; Morin P; Touaibia M
    J Biol Chem; 2012 Jun; 287(24):20164-75. PubMed ID: 22528487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of DLX2 confers a poor prognosis in glioblastoma patients by inducing a proliferative phenotype.
    Yan ZH; Bao ZS; Yan W; Liu YW; Zhang CB; Wang HJ; Feng Y; Wang YZ; Zhang W; You G; Zhang QG; Jiang T
    Curr Mol Med; 2013 Mar; 13(3):438-45. PubMed ID: 23331016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The STEMRI trial: Magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma stem-like cells.
    Lemarié A; Lubrano V; Delmas C; Lusque A; Cerapio JP; Perrier M; Siegfried A; Arnauduc F; Nicaise Y; Dahan P; Filleron T; Mounier M; Toulas C; Cohen-Jonathan Moyal E
    Sci Adv; 2023 Nov; 9(44):eadi0114. PubMed ID: 37922359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma.
    Boyrie S; Delmas C; Lemarié A; Lubrano V; Dahan P; Malric L; Luis J; Gilhodes J; Tosolini M; Mouly L; Lehmann M; Toulas C; Cohen-Jonathan Moyal E; Monferran S
    Oncotarget; 2018 Sep; 9(73):33788-33803. PubMed ID: 30333910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomic Characterization of Two Extracellular Vesicle Subtypes Isolated from Human Glioblastoma Stem Cell Secretome by Sequential Centrifugal Ultrafiltration.
    Di Giuseppe F; Carluccio M; Zuccarini M; Giuliani P; Ricci-Vitiani L; Pallini R; De Sanctis P; Di Pietro R; Ciccarelli R; Angelucci S
    Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33546239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sample Level Enrichment Analysis of KEGG Pathways Identifies Clinically Relevant Subtypes of Glioblastoma.
    Wanggou S; Feng C; Xie Y; Ye L; Wang F; Li X
    J Cancer; 2016; 7(12):1701-1710. PubMed ID: 27698907
    [No Abstract]   [Full Text] [Related]  

  • 35. Metabolic Heterogeneity Evidenced by MRS among Patient-Derived Glioblastoma Multiforme Stem-Like Cells Accounts for Cell Clustering and Different Responses to Drugs.
    Grande S; Palma A; Ricci-Vitiani L; Luciani AM; Buccarelli M; Biffoni M; Molinari A; Calcabrini A; D'Amore E; Guidoni L; Pallini R; Viti V; Rosi A
    Stem Cells Int; 2018; 2018():3292704. PubMed ID: 29531533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corrigendum: Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
    Network TC
    Nature; 2013 Feb; 494(7438):506. PubMed ID: 23389443
    [No Abstract]   [Full Text] [Related]  

  • 37. Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.
    Kim SH; Ezhilarasan R; Phillips E; Gallego-Perez D; Sparks A; Taylor D; Ladner K; Furuta T; Sabit H; Chhipa R; Cho JH; Mohyeldin A; Beck S; Kurozumi K; Kuroiwa T; Iwata R; Asai A; Kim J; Sulman EP; Cheng SY; Lee LJ; Nakada M; Guttridge D; DasGupta B; Goidts V; Bhat KP; Nakano I
    Cancer Cell; 2016 Feb; 29(2):201-13. PubMed ID: 26859459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance.
    Fidoamore A; Cristiano L; Antonosante A; d'Angelo M; Di Giacomo E; Astarita C; Giordano A; Ippoliti R; Benedetti E; Cimini A
    Stem Cells Int; 2016; 2016():6809105. PubMed ID: 26880981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of genetically engineered stem cells for glioma therapy.
    Namba H; Kawaji H; Yamasaki T
    Oncol Lett; 2016 Jan; 11(1):9-15. PubMed ID: 26870161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intratumoral heterogeneity identified at the epigenetic, genetic and transcriptional level in glioblastoma.
    Parker NR; Hudson AL; Khong P; Parkinson JF; Dwight T; Ikin RJ; Zhu Y; Cheng ZJ; Vafaee F; Chen J; Wheeler HR; Howell VM
    Sci Rep; 2016 Mar; 6():22477. PubMed ID: 26940435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.